The Chinese government is in the final stages of beginning a precision medicine initiative aimed toward creating a strong Chinese presence in the field of genome sequencing. Expected to be formally announced in March as part of the government’s next Five-Year Plan (2016–2020), preliminary estimates for funding of the initiative are around ¥60 billion ($9.2 […]
Skokie, IL 12/1/15—Integrated DNA Technologies (IDT) has agreed to acquire AITbiotech’s oligonucleotide synthesis business, which is based in Singapore. Financial details were not disclosed. IDT stated that the acquisition will expand its Southeast Asian customer base.
Chinese R&D spending grew 12.4% in 2014 to CNY 1,331.2 billion ($216 billion) or 2.09% of GDP. Five percent was for “fundamental research programs.” In 2013, R&D spending increased 15.0%. The number of authorized patents fell 0.8% in 2014 to 130,000. The number of product inspection labs totaled 27,051, of which 597 were national centers. […]
The Australian government has published a “National Innovation & Science Agenda,” to which AUD 1.1 billion ($80.3 million) will be allocated over four years. The Agenda consists of four pillars: Culture and Capital, Collaboration, Talent and Skills, and Government as an Exemplar. The pillar of Culture and Capital addresses funding shortfalls for technology development, and […]
China, the second largest drug market, has increased its commitment to its domestic pharmaceutical industry. This year, sales of the country’s 10 largest pharmaceutical companies grew an average of 12%, according to IMS Consulting. Multinational drug firms, including Novo Nordisk and GlaxoSmithKline, report increased competition. Domestic firms, such as Gan & Lee Pharmaceuticals and Fosun […]
Importing biomaterials, such as mice and plants, will become easier for Chinese companies and research institutes next year. Having been implemented on a trial basis for two years in Beijing and Shanghai, reforms of the current rules will increase the competitiveness of the country’s bioindustry and facilitate greater international collaboration with partners. Currently, China must […]
Following up on previous programs, in August, the Chinese government announced World Class 2.0, a plan for its best universities to attain world-class status. As revealed at the Organization for Economic Co-Operation and Development’s Higher Education Futures conference earlier this month, the program has been initiated despite some budgetary limitations. Under the plan, hubs for […]
This month, the Organization for Economic Co-operation and Development (OECD) released its annual Science, Technology and Industry Scoreboard, highlighting trends in R&D spending among the 34 countries that make up the OECD as well as China. In particular, the report emphasized the recent trends of growing investment by business, China’s increasing R&D prominence and the […]
Despite indications that the global economy is continuing to slow, the outlook for sales growth within the instrument and lab product industry is positive. In late October, 15 industry executives completed the online IBO Business Climate Survey. The respondents were IBO subscribers and other solicited participants, each representing a unique company or business unit. The […]
This month, New Zealand’s government released the “National Statement of Science Investment (NSSI) for 2015–2025.” The strategy’s 10-year goals are a simpler, more transparent science system investing effectively in the long term to benefit the country’s health, environment and society. The NSSI seeks to elevate New Zealand’s position as an R&D destination, and to regularly […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
